Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastoma
Open Access
- 1 April 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Abstract
Recent advances in cancer therapy have underscored the importance of targeting specific metabolic pathways. In this study, we propose a precision nutrition approach aimed at lysosomal function in glioblastoma multiforme (GBM). Using patient-derived GBM cells, we identify lysosomal activity as a unique metabolic biomarker of tumorigenesis, controlling the efficacy of temozolomide (TMZ), a standard GBM therapy. Employing combined analyses of clinical patient samples and xenograft models, we further elucidate the pivotal role of Transcription Factor Binding To IGHM Enhancer 3 (TFE3), a master regulator of lysosomal biogenesis, in modulating malignant properties, particularly TMZ tolerance, by regulating peroxisome proliferator-activated receptor-gamma coactivator 1−alpha (PGC1α)-mediated mitochondrial activity. Notably, we find that lysine protects GBM cells from lysosomal stress by counteracting arginine’s effects on nitric oxide production. The lysine restriction mimetic, homoarginine administration, significantly enhances the efficacy of anticancer therapies through lysosomal dysfunction. This study underscores the critical role of lysosomal function modulated by amino acid metabolism in GBM pathogenesis and treatment.Keywords
Funding Information
- Japan Agency for Medical Research and Development (21cm0106104h0006)
This publication has 73 references indexed in Scilit:
- Maintenance of Neural Stem-Progenitor Cells by the Lysosomal Biosynthesis Regulators TFEB and TFE3 in the Embryonic Mouse TelencephalonStem Cells, 2021
- Autophagy and organelle homeostasis in cancerDevelopmental Cell, 2021
- Mitochondrial Metabolism as a Target for Cancer TherapyCell Metabolism, 2020
- Dietary Approaches to Cancer TherapyCancer Cell, 2020
- Lysosomal Regulation of Inter-mitochondrial Contact Fate and Motility in Charcot-Marie-Tooth Type 2Developmental Cell, 2019
- Moving and positioning the endolysosomal systemCurrent Opinion in Cell Biology, 2017
- Understanding the Intersections between Metabolism and Cancer BiologyCell, 2017
- Mitochondrial Dynamics Controls T Cell Fate through Metabolic ProgrammingCell, 2016
- Investigating a signature of temozolomide resistance in GBM cell lines using metabolomicsJournal of Neuro-Oncology, 2015
- The effects of dietary protein and amino acids on skeletal metabolismMolecular and Cellular Endocrinology, 2015